myocardium~|~diarrhea~|~personnel selection~|~vomiting~|~wheezing~|~disease~|~specific qualifier value~|~diarrhea, ctcae~|~have diarrhea~|~how much distress diarrhea~|~how often diarrhea~|~myocardial~|~not otherwise specified~|~usual severity diarrhea~|~wasf1 gene~|~member~|~wave - physical agent~|~bothered by night sweats~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~night sweats~|~usual severity vomiting~|~vomiting, ctcae~|~wheezing, ctcae
dyspnea~|~dizziness~|~headache~|~disease~|~brief health literacy screening tool~|~behavior rating inventory of executive function~|~brief~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~count of entities~|~decision~|~have shortness of breath question~|~headache, ctcae~|~how much distress shortness of breath~|~how often shortness of breath~|~mdf attributetype - number~|~numbers~|~shortened~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~member
apnea~|~apnea, ctcae~|~not otherwise specified
fascia~|~entire fascia~|~not otherwise specified~|~suicide attempt incident code~|~suicide attempt, ctcae~|~suicide attempt
hemophilia a~|~2-hydroxyethyl methacrylate~|~n-acetyl-s-(2-hydroxyethyl)cysteine~|~jealousy~|~f8 gene~|~f8 wt allele~|~memory observations~|~not otherwise specified~|~nausea and vomiting
pain~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain~|~specific qualifier value
hypoglycemia~|~hypoglycemia, ctcae
helium~|~not otherwise specified~|~obstructed~|~cytip gene~|~chronic - admission level of care code~|~lengthened (qualifier value)~|~long~|~long variable~|~provision of recurring care for chronic illness~|~chronic
abdominal pain~|~andorra~|~reptiles~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~adjacent~|~behavioral change~|~changed status~|~changing~|~following~|~hour~|~mental state~|~specific qualifier value~|~subsequent trial activity~|~then~|~next - htmllinktype~|~abdominal pain, ctcae 5~|~specified time~|~time range
wiskott-aldrich syndrome~|~diamond~|~disease~|~united arab emirates~|~personnel selection~|~was protein, human~|~wheezing~|~chills~|~member~|~androgen response element~|~chills, ctcae~|~diamond spl shape~|~numerous~|~server (computer)~|~several~|~true~|~was gene~|~washoe language~|~are unit of measure~|~server (role)~|~wheezing, ctcae
fatigue~|~row - table~|~cdisc sdtm body position terminology~|~not otherwise specified~|~position of phenotypic abnormality~|~positioning attribute~|~post~|~post device~|~row (arrangement)~|~slc35g1 gene~|~fatigue subordinate domain~|~fatigue, ctcae 5.0~|~feel fatigue
hypothermia (central) (local)~|~hypothermia due to exposure~|~hypothermia, ctcae~|~hypothermia, natural~|~signs and symptoms~|~changed status~|~changing~|~have~|~mental state~|~not otherwise specified~|~general symptom
pain~|~tea~|~chest pain~|~specific qualifier value~|~andorra~|~not otherwise specified~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~chest pain:finding:point in time:^patient:ordinal~|~and~|~and - dosing instruction fragment~|~atrophoderma vermiculatum~|~avar language~|~injury of lower leg~|~relationshipconjunction - and~|~tea dosage form category~|~thoracic epidural analgesia~|~amsacrine/azacitidine/etoposide~|~administration method - pain~|~adverse event associated with pain~|~extrinsic~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~igsf6 gene~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
hyperventilation~|~andorra~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~lupus erythematosus tumidus~|~not otherwise specified~|~specific qualifier value~|~she gene~|~she chinese
asthma~|~specific qualifier value~|~patients~|~respiration disorders~|~signs and symptoms~|~asthma pathway~|~bottom~|~disabled person code - patient~|~few~|~in addition to~|~mail claim party - patient~|~relationship modifier - patient~|~report source - patient~|~respiratory tract diseases~|~specimen source codes - patient~|~specimen type - patient~|~tablecellverticalalign - bottom~|~veterinary patient~|~with - dosing instruction fragment~|~general symptom
urine~|~dyspnea~|~andorra~|~singer~|~singing~|~color~|~pre-eclampsia~|~shock~|~urination~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~collapse (finding)~|~collapse (morphologic abnormality)~|~collapse of device~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~no effort~|~no hand mobility~|~no support needed~|~none~|~none (no infant feeding)~|~none - action taken in response to the event~|~none - additive/preservative~|~none - containerseparator~|~none - eligibility source~|~none - language proficiency~|~none - observationvalue~|~none - relationship~|~none - sequencing~|~none - specimen additive~|~none device~|~null value~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~singapore zebrafish~|~specific qualifier value~|~usual severity shortness of breath~|~none - responselevel~|~none - substanceadminsubstitution~|~none - tablerules~|~color assessment~|~color quantity~|~coloring excipient~|~color - fdalabeldata~|~color - solid dosage form~|~color additive
optic atrophy 1~|~quercus~|~histone acetyltransferase~|~specific qualifier value~|~united arab emirates~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole~|~hac protocol~|~ptpns1 protein, human~|~andorra~|~and~|~and - dosing instruction fragment~|~androgen response element~|~breast-impact of treatment scale~|~butting~|~hadh gene~|~haitian creole language~|~hat - headwear~|~have~|~not otherwise specified~|~oak preparation~|~relationshipconjunction - and~|~sirpa gene~|~sirpa wt allele~|~tmprss11d gene~|~are unit of measure~|~bit - unit of measure~|~open wound
specific qualifier value
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~pain~|~bcr protein, human~|~not otherwise specified~|~specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~all - localmarkupignore~|~all - tablerules~|~all~|~bcr gene~|~bcr wt allele~|~generalized~|~nutrition, calories~|~universal restriction modifier (core metadata concept)~|~calorie unit of energy~|~400~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
nurse administrator~|~diazooxonorleucine~|~andorra~|~influenza virus~|~orthomyxoviridae~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~friend~|~breath~|~communication contact~|~contact - hl7 attribution~|~contact with~|~container status - identified~|~friends - (religious affiliation)~|~have~|~identified~|~not otherwise specified~|~personal contact~|~physical contact~|~possess~|~shop (environment)~|~shopping (activity)~|~contact person
valine~|~united arab emirates~|~in addition to~|~parameter value~|~vermis of anterior lobe~|~valine measurement~|~with - dosing instruction fragment~|~androgen response element~|~aspen, bach flower essence~|~not otherwise specified~|~are unit of measure
mental state~|~not otherwise specified~|~pink color
short interspersed nucleotide elements~|~dehydration~|~poisoning~|~andorra~|~and~|~and - dosing instruction fragment~|~biological factors~|~dehydration procedure~|~dehydration, ctcae~|~drugs - dental services~|~pharmaceutical preparations~|~relationshipconjunction - and~|~specific qualifier value~|~tension~|~determined by~|~general medical service~|~generalized~|~safety reporting documentation~|~thinking, function~|~united states military commissioned officer o10
valine~|~pain~|~not otherwise specified~|~chills~|~chills, ctcae~|~in addition to~|~nck-interacting protein with sh3 domain~|~nckipsd gene~|~nckipsd wt allele~|~parameter value~|~vermis of anterior lobe~|~valine measurement~|~with - dosing instruction fragment~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain in limb, lower leg~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
dyspnea~|~andorra~|~major depressive disorder~|~unipolar depression~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~behavior~|~adjacent~|~behavior:-:point in time:^patient:-~|~emotional well-being~|~emotional state observations~|~emotional states~|~following~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~involvement with~|~not otherwise specified~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~subsequent trial activity~|~then~|~usual severity shortness of breath~|~next - htmllinktype~|~language ability - sign~|~muscle strain~|~physical findings
wiskott-aldrich syndrome~|~hot temperature~|~septic shock~|~severe sepsis~|~sepsis~|~septicemia~|~was protein, human~|~chills~|~disease~|~in addition to~|~with - dosing instruction fragment~|~adhfe1 gene~|~chills, ctcae~|~female dog~|~hot sensation quality~|~human study subject~|~investigative subject~|~organism~|~rapid~|~sepsis (invertebrate)~|~sepsis, ctcae~|~specific qualifier value~|~study subject~|~subject - topic~|~subject -direct target~|~was gene~|~washoe language~|~member~|~respiration intermittent
back pain~|~not otherwise specified~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0
chest pain~|~alcohol consumption~|~fighting~|~in addition to~|~intoxication~|~specific qualifier value~|~with - dosing instruction fragment~|~chest pain:finding:point in time:^patient:ordinal
communicable diseases~|~andorra~|~somnolence~|~specific qualifier value~|~adverse event associated with infection~|~and~|~and - dosing instruction fragment~|~changed status~|~changing~|~drowsiness~|~drowsiness visual analogue scale~|~exception - property or attribute~|~have~|~infection~|~mental state~|~not otherwise specified~|~organism~|~post~|~relationshipconjunction - and~|~skiing (recreational activity)~|~status post~|~subcutaneous route of drug administration~|~exception - responselevel~|~subcutaneous~|~local~|~local remote control state - local~|~local-regional anatomy
abdominal pain~|~united arab emirates~|~not otherwise specified~|~specific qualifier value~|~androgen response element~|~aspen, bach flower essence~|~change -- procedure~|~changed status~|~changing~|~delta (difference)~|~mental state~|~tension~|~are unit of measure~|~abdominal pain, ctcae 5~|~abdominal tenderness
transient ischemic attack~|~andorra~|~shock~|~plumbing~|~singing~|~paint~|~and~|~and - dosing instruction fragment~|~collapse (finding)~|~collapse (morphologic abnormality)~|~collapse of device~|~relationshipconjunction - and~|~entity~|~singapore zebrafish~|~game
asthma~|~chest pain~|~personnel selection~|~funds~|~left upper quadrant pain~|~right upper quadrant pain~|~advice~|~asthma pathway~|~busy~|~exacerbation~|~in addition to~|~with - dosing instruction fragment~|~member~|~chest pain:finding:point in time:^patient:ordinal
specific qualifier value
female dog~|~not otherwise specified
pain~|~myocardium~|~chest pain~|~acute myocardial infarction~|~elevation~|~elevation procedure~|~external cause codes: unspecified~|~myocardial~|~not otherwise specified~|~send (transmission)~|~specific qualifier value~|~standard for the exchange of nonclinical data~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~walls of a building~|~administration method - pain~|~adverse event associated with pain~|~chest pain:finding:point in time:^patient:ordinal~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
month of may~|~not otherwise specified~|~traumatic and/or non-traumatic injury~|~traumatic injury
abdominal pain~|~dyspnea~|~albania~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~intravascular line~|~line specimen~|~line unit of length~|~linear~|~long interspersed elements~|~not otherwise specified~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~line source specimen code~|~abdominal pain, ctcae 5~|~nadia - zebrafish
station~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~generalized abdominal pain~|~hypertensive disease~|~nausea or abdominal pain
xerostomia~|~specific qualifier value~|~dry mouth, ctcae~|~have dry mouth~|~how much distress dry mouth~|~how often dry mouth~|~usual severity dry mouth
dyspnea~|~india~|~andorra~|~acute - triage code~|~admission level of care code - acute~|~and~|~and - dosing instruction fragment~|~count of entities~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~india - zebrafish~|~mdf attributetype - number~|~numbers~|~relationshipconjunction - and~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~acute~|~acute inpatient encounter
not otherwise specified~|~tennis (activity)
nurse administrator~|~tachycardia~|~pain~|~diazooxonorleucine~|~dyspnea~|~chest pain~|~nausea~|~personnel selection~|~andorra~|~disease~|~and~|~and - dosing instruction fragment~|~bothered by nausea~|~feel nausea~|~have nausea~|~have shortness of breath question~|~how much distress nausea~|~how much distress shortness of breath~|~how much nausea during this period~|~how often nausea~|~how often shortness of breath~|~member organization~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~relationshipconjunction - and~|~role class - member~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specific qualifier value~|~usual severity nausea~|~usual severity shortness of breath~|~member~|~administration method - pain~|~adverse event associated with pain~|~chest pain:finding:point in time:^patient:ordinal~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~hypertensive disease~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
hac protocol~|~borg category-ratio 10 perceived exertion score 2~|~hadh gene~|~have~|~intensity and distress 1~|~mild (qualifier value)~|~slight (qualifier value)~|~specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury
dyspnea~|~urinary tract infection~|~equus asinus~|~andorra~|~not otherwise specified~|~ass1 gene~|~ass1 wt allele~|~academic research enhancement awards~|~and~|~and - dosing instruction fragment~|~area~|~childhood immunization~|~geographic locations~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~recurrent urinary tract infection~|~relationshipconjunction - and~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~side~|~this (eukaryote)~|~undifferentiated sex~|~unspecified~|~unspecified method of administration~|~urinary tract infection, ctcae~|~usual severity shortness of breath~|~chronic - admission level of care code~|~provision of recurring care for chronic illness~|~chronic
generalized abdominal pain
nausea~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~usual severity nausea
not otherwise specified~|~veneer
snake venoms~|~andorra~|~tachycardia~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~accidents~|~accidental~|~anthropological culture~|~cultural aspects~|~culture dose form~|~encounter~|~firstly~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~laboratory culture~|~microbial culture (procedure)~|~national citizen~|~patient visit~|~specific qualifier value~|~toxic effect~|~visit~|~intent~|~general symptom~|~language ability - sign~|~physical findings
crohn disease~|~memory~|~retained~|~body site modifier - lower~|~lower (action)~|~lower - spatial qualifier~|~memory device~|~memory g-code~|~memory observations~|~not otherwise specified~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~project~|~generalized abdominal pain~|~generalized aches and pains~|~left~|~left sided~|~right~|~right sided~|~table cell horizontal align - left~|~table cell horizontal align - right
chest pain~|~not otherwise specified~|~nothing~|~chest pain:finding:point in time:^patient:ordinal~|~fine - adjective~|~legal fine
aves~|~hallucinations, auditory~|~symptoms~|~hallucinations, visual~|~andorra~|~inpatient~|~facilitated oscillatory release technique~|~preposition for~|~wwox gene~|~wwox wt allele~|~burn injury~|~academic degree~|~and~|~and - dosing instruction fragment~|~bird regimen~|~degree unit of plane angle~|~degree or extent~|~domestic avian species~|~emotional well-being~|~emotional state observations~|~emotional states~|~first degree~|~gli3 gene~|~gli3 wt allele~|~involvement with~|~kalmia~|~levels (qualifier value)~|~nr4a2 gene~|~negation~|~pappa gene~|~pappa wt allele~|~patient class - inpatient~|~postaxial polydactyly type a~|~pyogenic arthritis, pyoderma gangrenosum and acne~|~referral category - inpatient~|~relationshipconjunction - and~|~side~|~specific qualifier value~|~symptoms aspect~|~this (eukaryote)~|~inpatient encounter~|~burn specimen~|~burn specimen source codes~|~burn, ctcae~|~fine - adjective~|~legal fine~|~periodontal screening and recording code 2~|~second degree~|~thermal decomposition of device~|~usage~|~use - dosing instruction imperative~|~utilization qualifier
nurse administrator~|~diazooxonorleucine~|~changed status~|~changing~|~have~|~mental state~|~nr4a2 gene~|~negation~|~specific qualifier value
specific qualifier value
health~|~generalized~|~specific qualifier value~|~tests (qualifier value)~|~blood products laboratory testing~|~generalized abdominal pain~|~generalized aches and pains~|~laboratory procedures~|~loading technique~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing
tachycardia~|~disease~|~tissue membrane~|~member~|~stomach ache
chest pain~|~caucasoid race~|~wound healing~|~cabinet~|~not otherwise specified~|~caucasians~|~chest pain:finding:point in time:^patient:ordinal~|~repair~|~repair - remedial action~|~surgical repair~|~white color
precision - year~|~specific qualifier value~|~this (eukaryote)~|~transaction counts and value totals - year~|~year
andorra~|~symptoms~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~behavior~|~behavior:-:point in time:^patient:-~|~drop (unit of presentation)~|~drop - unit of volume~|~drop british~|~drop dosing unit~|~dropping~|~drops - drug form~|~emotional well-being~|~emotional state observations~|~emotional states~|~involvement with~|~medical drop~|~symptoms aspect~|~used by~|~drain - specimentype~|~drain specimen code~|~drain device~|~drainage procedure~|~language ability - sign~|~physical findings
not otherwise specified
fluorescent in situ hybridization~|~biography~|~poisoning~|~andorra~|~fishes~|~awareness~|~comment~|~septicemia~|~toxemia of pregnancy~|~training~|~training programs~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~health~|~alteration~|~bacterial toxemia~|~biological factors~|~comment domain~|~determined by~|~duration~|~duration (temporal concept)~|~duration brand of oxymetazoline~|~elf3 wt allele~|~encounter~|~fish (substance)~|~fish flavor~|~fish extract~|~healthcare encounter~|~metabolic~|~metabolic process, cellular~|~metabolic:-:point in time:^patient:-~|~not otherwise specified~|~patient visit~|~published comment~|~sh3pxd2a gene~|~sh3pxd2a wt allele~|~septic toxemia~|~show~|~visit~|~fish - non-drug agent~|~fish <actinopterygii>~|~fish <chondrichthyes>~|~fish <dipnoi>~|~fish <hyperoartia>~|~fish <hyperotreti>~|~lobe-finned fishes <coelacanthimorph>~|~poisoning aspects~|~processing id - training~|~respiration intermittent~|~training aspects
specific qualifier value~|~possession
asthma~|~dyspnea~|~asthma pathway~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~decision~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specific qualifier value~|~usual severity shortness of breath
diarrhea~|~diarrhea, ctcae~|~have diarrhea~|~how much distress diarrhea~|~how often diarrhea~|~specific qualifier value~|~usual severity diarrhea
pain~|~happiness~|~not otherwise specified~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
cell respiration~|~intestinal obstruction~|~respiration~|~not otherwise specified~|~facilitated oscillatory release technique~|~preposition for~|~wwox gene~|~wwox wt allele~|~respiratory gaseous exchange in organisms~|~abdominal tenderness~|~generalized abdominal pain~|~nausea or abdominal pain
united arab emirates~|~androgen response element~|~not otherwise specified~|~are unit of measure
chest pain~|~dyspnea~|~nausea~|~chest pain:finding:point in time:^patient:ordinal~|~bothered by nausea~|~feel nausea~|~have nausea~|~have shortness of breath question~|~how much distress nausea~|~how much distress shortness of breath~|~how much nausea during this period~|~how often nausea~|~how often shortness of breath~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity nausea~|~usual severity shortness of breath~|~chest pain on breathing~|~right~|~right sided~|~table cell horizontal align - right
fees~|~andorra~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~drugs - dental services~|~generalized~|~not otherwise specified~|~pharmaceutical preparations~|~unknown (origin) (qualifier value)~|~very~|~very much~|~african american~|~african race~|~black - structured product labeling color~|~black color~|~black race~|~flat shape~|~residential flat
tachycardia~|~canis familiaris~|~wheezing~|~disease~|~dog antigen~|~dog family~|~not otherwise specified~|~wheezing, ctcae
dehydration~|~andorra~|~angola~|~attention~|~hypoglycemia~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~behavior~|~able to concentrate question~|~adjacent~|~attention g-code~|~behavior:-:point in time:^patient:-~|~concentration measurement~|~dehydration procedure~|~dehydration, ctcae~|~fbxw7 gene~|~fbxw7 wt allele~|~following~|~hypoglycemia, ctcae~|~mental concentration~|~message~|~specific qualifier value~|~subsequent trial activity~|~then~|~transaction counts and value totals - week~|~next - htmllinktype~|~week
pneumonia~|~dyspnea~|~andorra~|~disease~|~and~|~and - dosing instruction fragment~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~member organization~|~organism~|~relationshipconjunction - and~|~role class - member~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specific qualifier value~|~usual severity shortness of breath~|~member
not otherwise specified
diabetes mellitus~|~united arab emirates~|~back pain~|~guyana~|~hyperglycemia~|~specific qualifier value~|~androgen response element~|~glucose in blood specimen above reference range~|~have~|~hyperglycemia, ctcae~|~in addition to~|~not otherwise specified~|~possess~|~send (transmission)~|~tendency to fall~|~with - dosing instruction fragment~|~are unit of measure~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~entity determiner - specific
alcohol related disorders~|~dinner~|~alcohol consumption~|~andorra~|~specific qualifier value~|~and~|~and - dosing instruction fragment~|~ideation~|~relationshipconjunction - and~|~with dinner~|~general symptom~|~language ability - sign~|~physical findings
asthma~|~nurse administrator~|~diazooxonorleucine~|~dyspnea~|~dizziness~|~personnel selection~|~wheezing~|~asthma pathway~|~exacerbation~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~in addition to~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specific qualifier value~|~usual severity shortness of breath~|~with - dosing instruction fragment~|~member~|~wheezing, ctcae
sinoatrial node~|~cardiac arrhythmia~|~artificial cardiac pacemaker~|~defibrillators~|~heart~|~adverse event associated with cardiac arrhythmia~|~automated (qualifier value)~|~cardiac - anatomy qualifier~|~clinical~|~clinical batch~|~clinical lot~|~cousin~|~in addition to~|~specific qualifier value~|~with - dosing instruction fragment
chest pain~|~physical examination~|~medical examination~|~signs and symptoms~|~chat gene~|~catha edulis (substance)~|~choline o-acetyltransferase, human~|~counter brand of terbufos~|~counter device~|~encounter~|~encounter due to unspecified general medical examination~|~examination~|~facilitated oscillatory release technique~|~health checkup~|~healthcare encounter~|~home environment~|~house (environment)~|~merluccius merluccius~|~not otherwise specified~|~patient visit~|~preposition for~|~sh2d3c gene~|~sh2d3c wt allele~|~specified by~|~then~|~then - dosing instruction fragment~|~visit~|~wwox gene~|~wwox wt allele~|~without~|~admission type - routine~|~chest pain:finding:point in time:^patient:ordinal~|~experimental finding~|~extended priority codes - routine~|~finding~|~how often felt normal question~|~level of care - routine~|~normal~|~normal gait~|~normal immune presence~|~normal observation interpretation~|~normal reference range~|~normal assessment finding~|~normal, unit of concentration~|~priority - routine~|~processing priority - routine~|~referral priority - routine~|~report priority - routine~|~routine~|~skin appearance normal (finding)~|~normal act status~|~normal confidentiality~|~normal device alert level~|~normal entity status~|~normal managed participation status~|~normal role status
gastritis~|~back pain~|~nausea~|~bothered by nausea~|~feel nausea~|~gastritis, ctcae~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~usual severity nausea~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~generalized abdominal pain
facilitated oscillatory release technique~|~message~|~preposition for~|~specific qualifier value~|~this (eukaryote)~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~wwox gene~|~wwox wt allele
vomiting~|~in addition to~|~with - dosing instruction fragment~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~nadia - zebrafish~|~usual severity vomiting~|~vomiting, ctcae
changed status~|~changing~|~mental state~|~not otherwise specified
andorra~|~cardiac arrest~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~fine - adjective~|~legal fine~|~aspects of mortality statistics~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~cardiac arrest, ctcae 5~|~decision~|~mortality vital statistics~|~motel~|~off~|~specific qualifier value~|~i don't know
dehydration~|~food~|~back pain~|~specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~back~|~back structure, excluding neck~|~back structure, including back of neck~|~dehydration procedure~|~dehydration, ctcae~|~dorsal~|~entire back (surface region)~|~food allergenic extracts~|~not otherwise specified~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0
changed status~|~changing~|~not otherwise specified~|~teacher
poisoning~|~andorra~|~ability~|~anger~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~motion~|~signs and symptoms~|~biological factors~|~feeling suicidal (finding)~|~geographic state~|~involvement with~|~specific qualifier value~|~state~|~state ownership~|~suicidal ideation, ctcae~|~suicidal ideation:find:pt:^patient:nom~|~us state~|~determined by~|~did you read~|~nucleotide sequence read~|~reading (activity)~|~reading (datum presentation)
united arab emirates~|~andorra~|~and~|~and - dosing instruction fragment~|~androgen response element~|~montana (geographic location)~|~montana <invertebrate>~|~not otherwise specified~|~relationshipconjunction - and~|~are unit of measure
menogaril~|~multiple endocrine neoplasia~|~poisoning~|~andorra~|~somnolence~|~and~|~and - dosing instruction fragment~|~changed status~|~changing~|~not otherwise specified~|~relationshipconjunction - and~|~mentors~|~biological factors~|~drowsiness~|~drowsiness visual analogue scale~|~father (person)~|~father - courtesy title~|~indirect exposure mechanism - father~|~medina~|~pharmaceutical preparations~|~pharmacologic substance~|~relationship - father~|~specific qualifier value~|~stage~|~teacher~|~determined by~|~ell gene~|~ell wt allele~|~general symptom~|~male population group~|~mende language
carney complex~|~poisoning~|~aves~|~automobiles~|~alcohol consumption~|~specific qualifier value~|~andorra~|~and~|~and - dosing instruction fragment~|~bird regimen~|~biological factors~|~caronte~|~cdisc adas-cog - commands summary score~|~cxadr gene~|~cxadr wt allele~|~cxadrp1 gene~|~car - mode of arrival code~|~car <insecta>~|~carib language~|~chimeric antigen receptor~|~coxsackievirus and adenovirus receptor, human~|~domestic avian species~|~in addition to~|~intoxication~|~nr1i3 gene~|~nr1i3 wt allele~|~nr4a2 gene~|~negation~|~prkar1a wt allele~|~relationshipconjunction - and~|~spg7 gene~|~trim13 wt allele~|~with - dosing instruction fragment~|~actomyosin contractile ring~|~determined by
dizziness~|~lightheadedness~|~changed status~|~changing~|~hypothermia (central) (local)~|~hypothermia due to exposure~|~hypothermia, ctcae~|~hypothermia, natural~|~injection of therapeutic agent~|~make - instruction imperative~|~manufacturer name~|~mental state~|~not otherwise specified~|~shox2 gene~|~shot (injury)~|~shot dosing unit
pain~|~not otherwise specified~|~specific qualifier value~|~andorra~|~face~|~have~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~actual~|~and~|~and - dosing instruction fragment~|~changed status~|~changing~|~elovl6 gene~|~entire face~|~entire tendon~|~fance wt allele~|~fanconi anemia, complementation group e~|~face (spatial concept)~|~half~|~mental state~|~multiple of the median~|~post~|~real data type~|~relationshipconjunction - and~|~status post~|~tendon structure~|~mycolate outer membrane~|~trauma to the abdomen~|~administration method - pain~|~adverse event associated with pain~|~awake~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
pain~|~rnf31 gene~|~specific qualifier value~|~chapter~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
united arab emirates~|~androgen response element~|~not otherwise specified~|~are unit of measure
lightheadedness~|~dizziness~|~fatigue~|~not otherwise specified~|~postal address use - public~|~public entity~|~fatigue subordinate domain~|~fatigue, ctcae 5.0~|~feel fatigue
headache~|~hallucinations, visual~|~headache, ctcae~|~symptoms and signs involving emotional state
mentors~|~changed status~|~changing~|~not otherwise specified~|~teacher
muscle cramp~|~spasm~|~personnel selection~|~disease~|~approximate~|~kantr gene~|~lrpap1 gene~|~rack~|~rapa nui language~|~tmem79 gene~|~member~|~shopping (activity)~|~shopping:-:point in time:^patient:-
acute lymphocytic leukemia~|~asthma~|~precursor cell lymphoblastic leukemia lymphoma~|~hyperventilation~|~bcr protein, human~|~symptoms~|~all~|~asthma pathway~|~bcr gene~|~bcr wt allele~|~emotional well-being~|~emotional state observations~|~emotional states~|~exacerbation~|~in addition to~|~involvement with~|~symptoms aspect~|~this (eukaryote)~|~universal restriction modifier (core metadata concept)~|~with - dosing instruction fragment~|~all - localmarkupignore~|~all - tablerules~|~fine - adjective~|~legal fine
neoplasm metastasis~|~andorra~|~kinetics~|~fingers~|~back pain~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~specific qualifier value~|~leg injuries~|~aroma <invertebrate>~|~fingers, unit of measurement~|~fragrance (odor)~|~have~|~lower back (surface region)~|~lower back structure~|~not otherwise specified~|~possess~|~recovering from~|~since~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~sensory aroma~|~amount type - rate~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~igsf6 gene~|~injury of right hand~|~rate~|~rating (action)~|~secondary to~|~metastatic qualifier~|~second (number)
dehydration~|~g force~|~not otherwise specified~|~changed status~|~changing~|~dehydration procedure~|~dehydration, ctcae~|~geographic state~|~have~|~state~|~state ownership~|~us state~|~blood group antigen g (substance)~|~gauss~|~giga~|~gravitational constant~|~hiv subtype g~|~lower case roman letter g~|~maxillary left lateral primary incisor~|~point of glabella~|~unit of gravity~|~gram~|~upper case gee
not otherwise specified